ArticleFrontiers in medicine2026
Case Report and literature review: complications of the association between rheumatoid arthritis and tuberculosis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary tuberculosis is one of the major public health issues globally. According to the World Health Organization, it is among the top 10 causes of death caused by a single pathogen. In Romania, its reported incidence rate in 2024 was approximately 60 per 100,000 people, making it the country with the highest incidence in Europe. Rheumatoid arthritis (RA) is a systemic chronic autoimmune inflammatory disease characterized by the destruction of the small joints along with symmetrical distribution and multiorgan involvement. Pulmonary manifestations are more common in males with positive serology and can involve the lungs, airways, or pleura. Short-term corticotherapy may be initiated in patients with severe symptoms, and biological therapy (anti-TNF alpha drugs) may be used in those with inefficiency of disease-modifying antirheumatic drugs, with an increased risk for disseminated forms of tuberculosis in those with latent infection. Case description: We present the case of a 38-year-old male patient with a 5-year history of seropositive RA who was treated with methotrexate and methylprednisolone, without any prior investigations for latent tuberculosis infection or any chest radiography performed, and was admitted with severe respiratory failure. The results of thoracic computed tomography showed bilateral pneumothorax and pneumomediastinum, with pulmonary lesions suggestive of a diagnosis of tuberculosis, which was confirmed by bacteriological testing of samples. Conclusion: The coexistence of two severe diseases-one requiring immunosuppressive treatment and the other one favored by immunosuppression-in a country with a high prevalence of tuberculosis infection and in the absence of latent tuberculosis infection screening or periodic pulmonological assessment can lead to severe, life-threatening complications that require complex, multidisciplinary, long-term, and expensive management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.